首页 > 最新文献

Indian Journal of Medical Ethics最新文献

英文 中文
Nancy Olivieri: Sometimes, truth has only one face 南希-奥利维里:有时候,真相只有一面
Pub Date : 2024-04-12 DOI: 10.20529/ijme.2024.022
Sandhya Srinivasan
{"title":"Nancy Olivieri: Sometimes, truth has only one face","authors":"Sandhya Srinivasan","doi":"10.20529/ijme.2024.022","DOIUrl":"https://doi.org/10.20529/ijme.2024.022","url":null,"abstract":"","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"110 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140709082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on emerging infectious diseases: pros and cons of centralised government controls 新发传染病研究:政府集中控制的利弊
Pub Date : 2024-02-29 DOI: 10.20529/ijme.2024.016
R. Vaman
{"title":"Research on emerging infectious diseases: pros and cons of centralised government controls","authors":"R. Vaman","doi":"10.20529/ijme.2024.016","DOIUrl":"https://doi.org/10.20529/ijme.2024.016","url":null,"abstract":"","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"57 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140414579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transgender persons and structural intersectionality: Towards menstrual justice for all menstruators in India 变性人与结构交叉性:为印度所有月经使用者实现月经公正
Pub Date : 2024-02-28 DOI: 10.20529/ijme.2024.015
Muskan Tibrewala
Government policies concerning access to menstrual hygiene primarily focus on adolescent girls and women, leaving out transgender individuals. Addressing access to menstrual hygiene for transgender persons will require two key steps: first, their inclusion in current policies, and second, framing additional policies to address specific needs. Due to the absence of specific studies on this subject, this commentary relies on personal narratives and international studies. Improving access to menstrual hygiene among transgender individuals will require the enhancing of the availability of menstrual hygiene products, mitigating of stigma and fear of harassment, sensitising of healthcare workers, and ensuring the availability of proper washrooms. In addition, addressing the menstrual injustice experienced by transgender persons involves addressing socioeconomic factors such as caste, poverty, and access to education. Using the lens of structural intersectionality, this article undertakes a review of oppressive systems causing menstrual injustice. This approach is intended to enable policymakers and researchers to consider the multifaceted identities of menstruators, fostering a holistic understanding that will inform their approach towards achieving menstrual equality.
政府有关经期卫生的政策主要关注少女和妇女,而忽略了变性人。要解决变性人获得经期卫生的问题,需要采取两个关键步骤:首先,将其纳入现行政策;其次,制定额外政策以满足特定需求。由于缺乏对这一主题的具体研究,本评论依赖于个人叙述和国际研究。要改善变性人的经期卫生状况,就需要增加经期卫生用品的供应,减少耻辱感和对骚扰的恐惧,提高医护人员的敏感度,并确保提供适当的盥洗室。此外,要解决变性人在经期遭受的不公正待遇,还需要解决种姓、贫困和受教育机会等社会经济因素。本文以结构交叉性为视角,对造成月经不公的压迫性制度进行了回顾。这种方法旨在使政策制定者和研究人员能够考虑月经使用者的多方面身份,促进整体理解,为他们实现月经平等提供参考。
{"title":"Transgender persons and structural intersectionality: Towards menstrual justice for all menstruators in India","authors":"Muskan Tibrewala","doi":"10.20529/ijme.2024.015","DOIUrl":"https://doi.org/10.20529/ijme.2024.015","url":null,"abstract":"Government policies concerning access to menstrual hygiene primarily focus on adolescent girls and women, leaving out transgender individuals. Addressing access to menstrual hygiene for transgender persons will require two key steps: first, their inclusion in current policies, and second, framing additional policies to address specific needs. Due to the absence of specific studies on this subject, this commentary relies on personal narratives and international studies. Improving access to menstrual hygiene among transgender individuals will require the enhancing of the availability of menstrual hygiene products, mitigating of stigma and fear of harassment, sensitising of healthcare workers, and ensuring the availability of proper washrooms. In addition, addressing the menstrual injustice experienced by transgender persons involves addressing socioeconomic factors such as caste, poverty, and access to education. Using the lens of structural intersectionality, this article undertakes a review of oppressive systems causing menstrual injustice. This approach is intended to enable policymakers and researchers to consider the multifaceted identities of menstruators, fostering a holistic understanding that will inform their approach towards achieving menstrual equality.","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"50 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140422092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer and caste inequality among rural women in South India 南印度农村妇女的癌症与种姓不平等问题
Pub Date : 2024-02-24 DOI: 10.20529/ijme.2024.014
Sre Ratha
{"title":"Cancer and caste inequality among rural women in South India","authors":"Sre Ratha","doi":"10.20529/ijme.2024.014","DOIUrl":"https://doi.org/10.20529/ijme.2024.014","url":null,"abstract":"","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"73 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140433992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of Covid-19 pandemic on the research portfolio and approval turnaround time at the Kenya Medical Research Institute Covid-19 大流行病对肯尼亚医学研究所研究组合和审批周转时间的影响
Pub Date : 2024-02-22 DOI: 10.20529/ijme.2024.013
Enock Kipchirchir Kebenei, Daisy Cheruiyot, Gideon Cornel Msee, James Nguya, T. Kiplagat, Elizabeth A Bukusi
Background: The Covid-19 pandemic led to unprecedented impact on many sectors globally including research. We assessed the impact of the Covid-19 pandemic on the research portfolio, and on the approval turnaround time for research protocols submitted to the Scientific and Ethics Review Unit (SERU), at the Kenya Medical Research Institute (KEMRI). Methods: We compared research protocols submitted between October 01, 2019 and March 31, 2020 (Period 1), to those submitted between April 1 and September 30, 2020 (Period 2). A document review tool was used to extract data from the 198 research protocols reviewed and approved over the two periods. Results: In the two periods under review, the single largest percentage of protocols (89/198, 45.4%) involved infectious and parasitic diseases, and the single largest percentage of study designs was cross-sectional (75/198, 38%). Before the pandemic, the median time taken to review KEMRI-linked protocols was 87 days and for non-KEMRI linked protocols it was 121 days. During the pandemic, approval turnaround time dropped for both KEMRI and non-KEMRI protocols to 66 days and 92 days, respectively, due to the streamlined processes at the KEMRI SERU. Conclusion: The research portfolio was minimally affected by the pandemic. The adoption of email submission, and faster-than-usual processing and review protocols during the pandemic reduced the approval turnaround time.
背景:Covid-19 大流行给全球许多领域(包括科研)带来了前所未有的影响。我们评估了 Covid-19 大流行对肯尼亚医学研究所 (KEMRI) 的研究组合以及提交给科学与伦理审查股 (SERU) 的研究方案审批周转时间的影响。方法:我们对 2019 年 10 月 1 日至 2020 年 3 月 31 日(期间 1)提交的研究方案与 2020 年 4 月 1 日至 9 月 30 日(期间 2)提交的研究方案进行了比较。我们使用文件审查工具从这两个时期审查和批准的 198 份研究方案中提取数据。结果:在审查的两个时期中,涉及传染病和寄生虫病的研究方案所占比例最大(89/198,45.4%),横断面研究设计所占比例最大(75/198,38%)。在大流行之前,审查与 KEMRI 相关的方案所需的时间中位数为 87 天,而审查与 KEMRI 无关的方案所需的时间中位数为 121 天。在大流行期间,由于 KEMRI SERU 简化了流程,KEMRI 和非 KEMRI 方案的审批周转时间分别降至 66 天和 92 天。结论研究项目组合受大流行病的影响很小。在大流行期间,采用电子邮件提交以及比平时更快的处理和审查规程缩短了审批周转时间。
{"title":"The impact of Covid-19 pandemic on the research portfolio and approval turnaround time at the Kenya Medical Research Institute","authors":"Enock Kipchirchir Kebenei, Daisy Cheruiyot, Gideon Cornel Msee, James Nguya, T. Kiplagat, Elizabeth A Bukusi","doi":"10.20529/ijme.2024.013","DOIUrl":"https://doi.org/10.20529/ijme.2024.013","url":null,"abstract":"Background: The Covid-19 pandemic led to unprecedented impact on many sectors globally including research. We assessed the impact of the Covid-19 pandemic on the research portfolio, and on the approval turnaround time for research protocols submitted to the Scientific and Ethics Review Unit (SERU), at the Kenya Medical Research Institute (KEMRI). Methods: We compared research protocols submitted between October 01, 2019 and March 31, 2020 (Period 1), to those submitted between April 1 and September 30, 2020 (Period 2). A document review tool was used to extract data from the 198 research protocols reviewed and approved over the two periods. Results: In the two periods under review, the single largest percentage of protocols (89/198, 45.4%) involved infectious and parasitic diseases, and the single largest percentage of study designs was cross-sectional (75/198, 38%). Before the pandemic, the median time taken to review KEMRI-linked protocols was 87 days and for non-KEMRI linked protocols it was 121 days. During the pandemic, approval turnaround time dropped for both KEMRI and non-KEMRI protocols to 66 days and 92 days, respectively, due to the streamlined processes at the KEMRI SERU. Conclusion: The research portfolio was minimally affected by the pandemic. The adoption of email submission, and faster-than-usual processing and review protocols during the pandemic reduced the approval turnaround time.","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"21 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140438519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Saviour siblings in India: A reminder of our existing challenges and biases 印度的救世主兄妹:提醒我们现有的挑战和偏见
Pub Date : 2024-02-17 DOI: 10.20529/ijme.2024.012
Salik Ansari, Harikeerthan Raghuram, A. Bhan
{"title":"Saviour siblings in India: A reminder of our existing challenges and biases","authors":"Salik Ansari, Harikeerthan Raghuram, A. Bhan","doi":"10.20529/ijme.2024.012","DOIUrl":"https://doi.org/10.20529/ijme.2024.012","url":null,"abstract":"","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"163 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140453345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public health ethics and the Kerala Public Health Act, 2023 公共卫生伦理与 2023 年《喀拉拉邦公共卫生法
Pub Date : 2024-01-27 DOI: 10.20529/ijme.2024.007
Sylvia Karpagam
This commentary looks at the Kerala Public Health Act (KPHA), passed on November 28, 2023, through the lens of public health ethics. While the Act recognises the importance of prevention and strengthening of social systems, it falters in the public health ethics and human rights framework, ignoring international public health principles such as the Siracusa Principles and guidelines for individual diseases such as tuberculosis. The Covid-19 pandemic in India itself offers ample learnings, which have been disregarded, on the need for caution against state overreach. Principles such as autonomy, privacy/confidentiality, transparency, accountability, rule of law, least harm etc have not even been given token consideration, making this law a potential tool of abuse, particularly against already vulnerable communities.
本评论从公共卫生伦理的角度审视了 2023 年 11 月 28 日通过的《喀拉拉邦公共卫生法》(KPHA)。虽然该法案承认预防和加强社会体系的重要性,但它在公共卫生伦理和人权框架方面存在缺陷,忽视了《锡拉库萨原则》等国际公共卫生原则以及针对肺结核等个别疾病的指导方针。印度的 Covid-19 大流行病本身就提供了充分的教训,即需要警惕国家过度干预,但这些教训却被忽视了。自治、隐私/保密、透明、问责、法治、最小伤害等原则甚至都没有得到象征性的考虑,这使得该法成为一种潜在的滥用工具,尤其是针对已经很脆弱的群体。
{"title":"Public health ethics and the Kerala Public Health Act, 2023","authors":"Sylvia Karpagam","doi":"10.20529/ijme.2024.007","DOIUrl":"https://doi.org/10.20529/ijme.2024.007","url":null,"abstract":"This commentary looks at the Kerala Public Health Act (KPHA), passed on November 28, 2023, through the lens of public health ethics. While the Act recognises the importance of prevention and strengthening of social systems, it falters in the public health ethics and human rights framework, ignoring international public health principles such as the Siracusa Principles and guidelines for individual diseases such as tuberculosis. The Covid-19 pandemic in India itself offers ample learnings, which have been disregarded, on the need for caution against state overreach. Principles such as autonomy, privacy/confidentiality, transparency, accountability, rule of law, least harm etc have not even been given token consideration, making this law a potential tool of abuse, particularly against already vulnerable communities.","PeriodicalId":503996,"journal":{"name":"Indian Journal of Medical Ethics","volume":"50 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140492010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Ethics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1